This is a
comprehensive account of the market size, segmentation, key players, SWOT
analysis, influential technologies, and business and economic environments. The
report is supported by 320 tables & figures over 280 pages.
This report is presented as follows:
- By Company (e.g., JANSSEN, MYLAN, ACTAVIS, GLAXOSMITHKLINE, BAYER, NOVARTIS, NOVEN, LAVIPHARM, PROSTRACKEN, NITTO DENTO)
- By Geography (Global, USA)
- By Parent Market (Drug Delivery Systems, Advanced Drug Delivery Systems)
- By Sub-market (Generics, Women’s Health, Analgesics, Neuropathic Pain)
A wealth of financial data & business strategy information
is provided including:
- Up-to-date company financials, sales & revenue figures
- Revenue and market forecasts
- Business model strategies for drug delivery, pharmaceutical and biotechnology companies
- Comprehensive account of company products, financials & portfolios
SWOT, Economic & Regulatory Environment specifics include:
- Key strengths, weaknesses and threats influencing leading player position within the market
- Technologies driving the market (e.g., chemical enhancers, microneedles)
- Top fastest growing market segments and emerging opportunities
- Top pharmaceutical companies within the market
- Comprehensive product portfolios, R&D activity and pipeline products
- M&A activity and future strategies of top companies
- High demand and unmet need enhances the market
- Challenges of the transdermal drug delivery market
Who should read this report?
- Pharmaceutical, biotechnology and diagnostic companies with an interest in personalized medicine
- Industry professionals and business strategists will discover key information to propel their policies
- Investors will gain inside information to dominant players in the industry and future forecasts
- Scientists will get a business perspective and industry insight into how scientific breakthroughs influence the market environment C-Suite professionals, Decision Makers, Business Development professionals
This report will tell you if the companies mentioned are:
- Strong, competitive players
- Pooling their resources for specific growth and therapeutic areas
- Investing strategically in R&D
- Have a history of strategic M&A activity
This detailed report
is supported with 320 figures and tables over 280 pages and profiles the main
pharmacos in the transdermal drug delivery market.
Benefits of Investing in our Cutting-Edge Reports:
- Clients receive complementary content* with mid-level and enterprise wide licences.
- Post-sale complementary consultation with senior expert analyst is included.
- Use of tables and figures in your own reports and presentations is permitted.
- Each report provides straight-talking strategic analysis & sector intelligence.
- All reports are updated each quarter to give you the most up-to-date information.
Spanning over 280 pages, “Global Transdermal Drug Delivery Market
to 2017” report covering the Executive Summary, Transdermal Drug
Delivery, Biomechanical and Pharmacological Elements Effecting Transdermal Drug
Delivery, Transdermal Drug Delivery Technologies, How Nanotechnology is
Transforming Transdermal Drug Delivery, Transdermal Drug Delivery and Disease
States, Gene Therapy and Transdermal Drug Delivery, Vaccines and Transdermal
Drug Technology, Global Drug Delivery Market, Transdermal Drug Delivery Company
Business Profiles and Strategic Evaluation, Transdermal Drug Delivery Company
Financial Analysis, Current Transdermal Drug Delivery Products on the Market,
In-Depth SWOT Analysis of the Transdermal Drug Delivery Market. The report
covered 23 companies are - 3M, AMAG Pharmaceuticals (Lumara Health, KV
Pharm/Ther-Rx Corp), Actavis, Actelion, Ascend Therapeutics, Bayer, Boehringer
Ingelheim, Endo International, GlaxoSmithKline, Hercon Pharmaceutical, Janssen
Pharmaceuticals, Kremers Urban Pharmaceuticals, Mylan Pharmaceuticals, Nitto
Denko, Novartis, Noven Pharmaceuticals, ParPharm, ProStrakan, Shire, Teikoku
USA, Teva Pharmaceutical Industries, UCB, Upsher-Smith.
For more information see – http://mrr.cm/44Z
Find all Drug Delivery Reports at: http://www.marketresearchreports.com/drug-delivery
No comments:
Post a Comment
Note: only a member of this blog may post a comment.